A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatment of Refractory Non-squamous Non-small Cell Lung Cancer with Leptomeningeal Metastases
Clinical trial NCT06901817 · RECRUITING
Trial details
- NCT number
- NCT06901817
- Sponsor
- Shanghai Cancer Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2027-11-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.